Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Looks like we followed the US today

<< Previous

Bullboard Posts

Next >>

Comment by Fruckedagainon Apr 25, 2024 5:16pm

161 Views

Post# 36008115

RE:Looks like we followed the US today

Verricodick. If I unload my shares at one time, I can drive this to 4 cents. This is not a great day for SBM shareholders.

The market experts are punishing this group a failed executives and will continue to do so until they prove there is money to be made here. And an amazon POS to sell some skin cream run by a wife of a CFO that happened to sell realestate is not going to cut it.

Fruckedagain is the story behind this after 16 years.

<< Previous

Bullboard Posts

Next >>

AI companies to invest in